Skip to main content

Closed

INCR: InterCure Ltd. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-10.1%

ROIC-4.7%

Financially safe

Stretched

Debt / equity0.46×

Interest coverage0.0×

Current ratio1.48×

InterCure Ltd.

INCRNASDAQ Global Market·USD·Closed

InterCure Ltd.

INCRNASDAQ·USD·Closed

$0.96

+1.41%

$0.96

+$0.01 (1.41%)

52W Range

26thpctl

Volume

0.36×avg

Mkt Cap

56.97MUSD

P/E

-4.4TTM

Div Yield

–ann

52W Range

26thpctl

Volume

0.36×avg

Market Cap

56.97MUSD

P/E Ratio

-4.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings